SEC Form 4 · accession 0001144204-15-072430
DERMA SCIENCES, INC. · DSCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederic Eigner
Officer — Executive VP - Operations
Period of report
Dec 20, 2015
Accepted (ET)
Dec 23, 2015 · 6:08 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000892160
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 20, 2015 | F | 3,750 | $4.48 | D | 49,224 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld in connection with the vesting of 7,500 restricted stock units, previously granted pursuant to the issuer's equity incentive plan as reported on December 21, 2012.